World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
53565
World Ranking
4695
National Ranking
2546

Overview

Paul Russo is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans across the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on subfields such as Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research, and Oncology.

The main topics of their research include renal cell carcinoma treatment, renal and related cancers, cancer genomics and diagnostics, bladder and urothelial cancer treatments, cancer immunotherapy and biomarkers, ferroptosis and cancer prognosis, and multiple and secondary primary cancers.

Paul Russo has contributed extensively to scientific literature, with notable papers including:

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients (2022, Cell)
  • Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy (2021, Cancer Cell)
  • Sarcomatoid renal cell carcinoma: biology, natural history and management (2020, Nature Reviews Urology)
  • Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial (2023, The Lancet)
  • Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma (2021, Clinical Cancer Research)

Frequent collaborators include:

  • A. Ari Hakimi
  • Jonathan Coleman
  • Robert J. Motzer
  • Martin H. Voss
  • Ritesh R. Kotecha

Paul Russo's contributions are often published in journals known for urology and oncology research. The most frequent publication venues are:

  • The Journal of Urology
  • Urologic Oncology Seminars and Original Investigations
  • Journal of Clinical Oncology
  • European Urology Open Science
  • Urology

Best Publications

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • Guideline for management of the clinical T1 renal mass.

    Steven C Campbell;Andrew C Novick;Arie S. Belldegrun;Michael L Blute

  • Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

    Robert J. Motzer;Jennifer Bacik;Barbara A. Murphy;Paul Russo

  • Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

    William C Huang;Andrew S Levey;Angel M Serio;Mark Snyder

  • Epidemiology of Renal Cell Carcinoma.

    Umberto Capitanio;Karim Bensalah;Axel Bex;Stephen A. Boorjian

  • Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

    Yasin Şenbabaoğlu;Ron S. Gejman;Ron S. Gejman;Andrew G. Winer;Ming Liu

  • Partial Nephrectomy Versus Radical Nephrectomy in Patients With Small Renal Tumors—Is There a Difference in Mortality and Cardiovascular Outcomes?

    William C. Huang;Elena B. Elkin;Andrew S. Levey;Thomas L. Jang

  • Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Jennifer Bacik;Lawrence H. Schwartz;Victor Reuter

  • A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA

    Michael W. Kattan;Victor Reuter;Robert J. Motzer;Jared Katz

  • SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT

    Cheryl T. Lee;Jared Katz;Weiji Shi;Howard T. Thaler

  • SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA

    Robert J. Motzer;Paul Russo

  • Resection of metastatic renal cell carcinoma.

    J. P. Kavolius;D. P. Mastorakos;C. Pavlovich;P. Russo

  • An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

    A. Ari Hakimi;Ed Reznik;Chung Han Lee;Chad J. Creighton

  • Natural history of chronic renal insufficiency after partial and radical nephrectomy

    James McKiernan;Rachel Simmons;Jared Katz;Paul Russo

  • A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

    Maximiliano Sorbellini;Michael W. Kattan;Mark E. Snyder;Victor Reuter

  • CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES

    Guido Dalbagni;Elizabeth Genega;Mia Hashibe;Zuo-Feng Zhang

  • Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell Histology

    Robert J. Motzer;Jennifer Bacik;Tania Mariani;Paul Russo

  • Assessing the Impact of Ischaemia Time During Partial Nephrectomy

    Frank Becker;Hendrik Van Poppel;Oliver W Hakenberg;Christian Stief

  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial

    Chaitanya R Divgi;Neeta Pandit-Taskar;Achim A Jungbluth;Victor E Reuter

  • Renal oncocytoma: A clinicopathologic study of 70 cases

    Bayardo Perez-Ordonez;Ghiath Hamed;Steven C Campbell;Robert A. Erlandson

Frequent Co-Authors

Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
James J. Hsieh
James J. Hsieh Washington University in St. Louis
Harry W. Herr
Harry W. Herr Memorial Sloan Kettering Cancer Center
Satish K. Tickoo
Satish K. Tickoo Memorial Sloan Kettering Cancer Center
Guido Dalbagni
Guido Dalbagni Memorial Sloan Kettering Cancer Center
Michael W. Kattan
Michael W. Kattan Cleveland Clinic
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
William R. Fair
William R. Fair Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare careers beyond traditional MD or DO programs, there are several flexible online degree pathways to consider. Many students explore most affordable DNP programs to advance their nursing expertise and leadership opportunities. These online Doctor of Nursing Practice degrees offer a route for nurses to achieve higher clinical and administrative roles while balancing work and study.

For those considering pharmacy, online pharmacy schools provide accredited doctorate options for aspiring pharmacists. These programs focus on clinical knowledge, pharmacology, and patient care, making it easier for working professionals to earn their degree remotely.

Alternatively, a HIM degree online is ideal for individuals interested in medical records, health data analysis, and healthcare IT. This pathway supports the growing demand for health information managers in hospitals, clinics, and insurance companies.

Additionally, those seeking quick entry into the medical field can look into medical billing and coding online courses. These programs allow students to gain certification and start working in healthcare administration in as little as a few months.

Best Scientists Citing Paul Russo

Trending Scientists